Longitudinal studies of cognitive, functional and behavioural change in patients with Alzheimer's disease

Statistics in Medicine

Volumn 19, Issue 11-12, 2000, Pages 1401-1409

  Mohs, Richard C ^a   Schmeidler, James ^a   Aryan, Mosen ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ANALYTIC METHOD; BEHAVIOR DISORDER; CLINICAL FEATURE; COGNITIVE DEFECT; CONFERENCE PAPER; DATA ANALYSIS; DIAGNOSTIC TEST; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; HUMAN; LONGITUDINAL STUDY;

EID: 0034660426     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1401::AID-SIM432>3.0.CO;2-X     Document Type: Conference Paper

References (32)

1. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944.
2. Morris JC, Heyman A, Mohs RC, Hughes J, van Belle G, Fillenbaum G, Mellits ED, Clark C and the CERAD investigators. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989; 39:1159-1165.
3. Welsh KA, Butters N, Hughes J, Mohs RC, Heyman A. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Archives of Neurology 1991; 48:278-281.
4. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975; 12:189-198.
5. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. American Journal of Psychiatry 1984; 141:1356-1364.
6. Stern RG, Mohs RC, Davidson M, Schmeidler J, Silverman JM, Kramer-Ginzberg E, Searcey T, Bierer LM, Davis KL. A longitudinal study of Alzheimer's disease: Measurement, rate and predictors of cognitive deterioration. American Journal of Psychiatry 1994; 151:390-396.
7. Skurla E, Rogers JC, Sunderland T. Direct assessment of activities of daily living in Alzheimer's disease: A controlled study. Journal of the American Geriatrics Society 1988; 36:97-103.
8. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffee MW. Studies of illness in the aged. The Index of ADL: A standardized measure of biological and psychosocial function. Journal of the American Medical Association 1963; 185:914-919.
9. Lawton C, Brodie E. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9:179-186.
10. Galasko D, Bennett D, Sano M, Ernesto C, Thomas R, Grundman M, Ferris SH. An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. Alzheimer's Disease and Associated Disorders 1997; 11(2):S33-S39.
11. Corelick EF, George LK. Predictors of institutionalization among caregivers of patients with Alzheimer's disease. Journal of the American Geriatrics Society 1986; 34:493-498.
12. Marin DB, Green CR, Schmeidler J, Harvey PD, Lawlor BA, Ryan T, Aryan M, Davis KL, Mohs RC. Noncognitive disturbances in Alzheimer's disease: Frequency, longitudinal course and relationship to cognitive symptoms. Journal of the American Geriatrics Society 1997; 45:1331-1338.
13. Cumming JL, Mega M, Gray K, Rosenberg-Thompgon S, Carusi DA, Cornbein J. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44:2308-2314.
14. Cohen-Mansfield J, Marx MS, Rosenthal AS. A description of agitation in a nursing home. Journal of Gerontology 1989; 44:M77-M84.
15. Heyman A, Peterson B, Fillenbaum G, Pieper C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XIV: Demographic and clinical predictors of survival in patients with Alzheimer's disease. Neurology 1996; 46:656-660.
16. Morris JC, Edland S, Clark C, Galasko D, Koss E, Mohs R, van Belle G, Fillenbaum G, Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology 1993; 43:2457-2465.
17. Farlow M, Gracon SI, Hershey LA, Lewis KW, Sadowsky CH, Dolan-Ureno J for the Tacrine Study Group. A controlled trial of tacrine in Alzheimer's disease. Journal of the American Medical Association 1992; 268:2523-2529.
18. Rogers SL, Farlow MR, Doody RS, Mohs RC, Friedhoff LT and the Donepezil Study Group. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology 1998; 50:136-145.
19. Welsh KA, Butters N, Hughes J, Mohs RC, Heyman A. Detection and staging of dementia in Alzheimer's disease: Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Archives of Neurology 1992; 49:448-452.
20. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growden J, Cotnman C, Pfeiffer E, Schneider LS, Thal LJ for the Members of the Alzheimer's Disease Cooperative Study. A controlled trial of selegelline, alpha-tocopherol, or both as treatment for Alzheimer's disease. New England Journal of Medicine 1997; 336:1216-1222.
21. Green CR, Mohs RC, Schmeidler J, Aryan M, Davis KL. Functional decline in Alzheimer's disease: A longitudinal study. Journal of the American Geriatrics Society 1993; 41:654-661.
22. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. British Journal of Psychiatry 1968; 114:797-811.
23. Schmeidler J, Mohs RC, Aryan M. Relationship of disease severity to decline on specific cognitive and functional measure in Alzheimer's disease. Alzheimer's Disease and Associated Disorders 1998; 12:146-151.
24. Devenand DP, Jacobs DM, Tang M-X, Castillo-Casteneda CD, Sano M, Marder K, Bell K, Bylsma FW, Brandt J, Albert M, Stern Y. The course of psychopathologic features in mild to moderate Alzheimer's disease. Archives of General Psychiatry 1997; 54:257-263.
25. Patterson MB, Mack JL, Mackell JA, Thomas R, Tariot P, Weiner M, Whitehouse PJ. A longitudinal study of behavioural pathology across five levels of dementia severity in Alzheimer's disease: The CERAD Behaviour Rating Scale for Dementia. Alzheimer's Disease and Associated Disorders 1997; 11(2):S40-S44.
26. Stern Y, Mayeux R, Sano M, Hauser WA, Bush T. Predictors of disease course in patients with probable Alzheimer's disease. Neurology 1987; 37:1649-1653.
27. Green CR, Marin DB, Mohs RC, Schmeidler J, Aryan M, Fine E, Davis KL. The impact of behavioural impairment on functional ability in Alzheimer's disease. International Journal of Geriatric Psychiatry 1999; 14:307-316.
28. Stern RG, Mohs RC, Bierer LM, Silverman JM, Schmeidler J, Davidson M, Davis KL. Deterioration on the Blessed test in Alzheimer's disease: Longitudinal data and their implications for clinical trials and identification of subtypes. Psychiatry Research 1992; 42:101-110.
29. McArdle JJ, Hamagami F. Modeling incomplete longitudinal data using latent growth structural models. Experimental Aging Research 1992; 18:145-166.
30. Gibbons RG, Hedeker D, Elkin I, Waternaux C, Kraemer HC, Greenhouse JB, Shea MT, Imber SD, Sotsky SM, Watkins JT. Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Archives of General Psychiatry 1993; 50:739-750.
31. Stern Y, Liu X, Albert M, Brandt J, Jacobs DM, Del Castillo-Casteneda C, Marder K, Bell K, Sano M, Bylsma F, Lafleche G, Tsai W-Y. Application of a growth curve approach to modeling the progression of Alzheimer's disease. Journal of Gerontology: Medical Sciences 1996; 51:M179-M184.
32. Brooks JO, III Kraemer HC, Tanke ED, Yesavage JA. The methodology of studying decline in Alzheimer's disease. Journal of the American Geriatrics Society 1993; 41:623-628.